Ian has over 40 years of product development, business development and project management experience in the biotechnology sector, both in Australia and the US. He has worked at an executive or board level with a range of companies, including CSL Ltd (17 years) and Millennium Pharmaceuticals Inc (7 years). He has been involved with the development of pharmaceutical products across multiple therapeutic areas (including oncology, inflammation, diabetes, Alzheimer’s Disease) and modalities (including small molecules, antibodies, cellular therapies and vaccines). He led the teams responsible for the development of two FDA-approved oncology drugs: VELCADE (bortezimib) and SYNRIBO (omacetaxine mepesuccinate). Ian is a co-founder of Cartherics Pty Ltd and serves as its COO, where he oversees activities such as product development, intellectual property, quality management, project management and finance. He also acts as Executive Director of Senz Oncology Pty Ltd, and as a director or advisor to several other biotechnology companies, including four US companies undertaking product development in Australia. Ian received his BSc in microbiology and biochemistry from the University of Melbourne and his PhD in molecular biology from Monash University. He is a graduate of the Advanced Management Program from the Melbourne Business School at the University of Melbourne.